（旧版）「喘息ガイドライン作成に関する研究」平成11年度研究報告書/ガイドライン引用文献(2000年まで)簡易版抄録を掲載

参考文献

1. Christie PE, Tagari P, Ford-Hutchinson AW, Black C, Markendorf A, Schmitz-Schumann M, Lee TH. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis 1992; 146: 1531-34.
2. Sladek K, Dworski R, Soja J, Sheller JR, Nizankowska E, Oates JA, Szczeklik A. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 149: 940-6.
3. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose JF, Austen FK, Holgate ST, Sampson AP. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 101: 834-46.
4. Robuschi M, Gambaro G, Sestini P, Pieroni MG, Refini RM, Vaghi A, Bianco S. Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium. Am J Respir Crit Care Med 1997; 155: 1461-4.
5. Yoshida S, Amayasu H, Sakamoto H, Onuma K, Shoji T, Nakagawa H, Tajima T. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Ann Allergy Asthma Immunol 1998; 80: 171-6.
6. Szczeklik A, Czerniawska-Mysik G, Serwonska M, Kuklinski P. Inhibition by ketotifen of idiosyncratic reaction to aspirin. Allergy 1980; 35: 421-4.
7. Yoshida S, Sakamoto H, Yamawaki Y, Shoji T, Akahori K, Onuma K, Nakagawa H, Hasegawa H, Amayasu H. Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma. J Allergy Clin Immunol 1998; 102: 909-14.
8. Szmidt M, Wasiak W. The influence of misoprostol(synthetic analogue of prostaglandin E1)on aspirin-induced bronchoconstriction in aspirin-sensitive asthma. J Invest Allergol Clin Immunol 1996; 6: 121-5.
9. Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, Robuschi M. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996; 153: 572-5.
10. Szczeklik A, Dworski R, Mastalerz L, Prokop A, Sheller JR, Nizankowska E, Cmiel A, Oates JA. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Am J Respir Crit Care Med 1998; 158: 1168-72.
11. Nasser SM, Bell GS, Foster S, Spruce KE, MacMillan R, Williams AJ, Lee TH, Arm JP. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Thorax 1994; 49: 749-56.
12. Christie PE, Smith CM, Lee TH. The potent and selective sulfidopeptide leukotriene antagonist, SK& F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis 1991; 144: 957-8.
13. Yamamoto H, Nagata M, Kuramitsu K, Tabe K, Kiuchi H, Sakamoto Y, Yamamoto K, Dohi Y. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist, ONO-1078. Am J Respir Crit Care Med 1994; 150: 254-7.
14. Dahlen B, Nizankowska E, Szczeklik A, Zetterstrom O, Bochenek G, Kimlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dube LM, Dahlen S-E. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998; 157: 1187-94. (I,B)
15. 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン1998.牧野荘平,古庄巻史,宮本昭正　監修.協和企画,東京,1998.(A)